Rocket One Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Rocket One Inc. (RKTO) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $625.49 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-14
- Rocket One Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $625.49K.
- Rocket One Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $219.93K, a 57.16% decline year-over-year.
- Rocket One Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-09-30 was $283.33K, a 48.91% increase year-over-year.
- Rocket One Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-06-30 was $7.05K, a 27.64% decline year-over-year.
- Rocket One Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $219.93K, a 72.66% decline from fiscal 2024.
- Rocket One Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $804.28K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $625.49K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $219.93K 10-K · filed 2026-03-27 | |||
| 2025-03-31 | $219.93K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $804.28K 10-K · filed 2026-03-27 | |||
| 2024-09-30 | $283.33K 10-Q · filed 2025-11-12 | $290.39K derived: sum of 2 quarters · filed 2025-11-12 | $803.74K derived: sum of 3 quarters · filed 2025-11-12 | |
| 2024-06-30 | $7.05K 10-Q · filed 2025-11-12 | $520.40K derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2024-03-31 | $513.35K 10-Q · filed 2025-11-12 | |||
| 2023-09-30 | $190.26K 10-Q · filed 2024-11-12 | $200.01K derived: sum of 2 quarters · filed 2024-11-12 | $210.64K derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $9.75K 10-Q · filed 2024-11-12 | $20.38K derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $10.63K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |